There are 519 papers on acute coronary syndrome in aging research: 52 trials and 354 observational studies in people, 1 in cells, 97 reviews.
121 new papers in 30 daysSee all 727 papers on acute coronary syndrome
“Participants in the iECG care group were less likely to have an acute coronary syndrome event during the follow-up period than in the RC group (10 vs. 21, P = 0.044; ).”
- Human trial52
- Humans354
- Cells1
- In silico4
Interventions
4GLP-1 receptor agonists
no changein humans1HR 0.83
1 study
GLP-1 receptor agonists
no changein humans1HR 0.83
GLP-1 receptor agonists were not clearly linked with acute coronary syndrome in humans (Type 2 diabetes and HR+/HER2-negative metastatic breast cancer receiving CDK4/6 inhibitors) (HR 0.83, 95% CI 0.56-1.236).
“No statistically significant difference was noted for VTE (HR 0.65 95% CI 0.39-1.09, p=0.098), arrhythmia (HR 0.77, 95% CI 0.5-1.2, p=0.245), or ACS (HR 0.83, 95% CI 0.56-1.236, p=0.341).”
HumansType 2 diabetes and HR+/HER2-negative metastatic breast cancer receiving CDK4/6 inhibitors5 yearsfemales
AHA Scientific Sessions 2026 abstract
Melatonin
no changein humans1
1 study
Melatonin
no changein humans1
Melatonin was not clearly linked with acute coronary syndrome in humans (0.55% vs. 0.56%, sRR 0.98 [0.89-1.06]).
“ACS (0.55% vs. 0.56%, sRR 0.98 [0.89-1.06])”
Humans5-year
Melatonin may be linked to slightly higher irregular heartbeat risk
ESC Congress 2026 abstract
Favorable environmental exposures
no changein humans1
1 study
Favorable environmental exposures
no changein humans1
Favorable environmental exposures were not clearly linked with acute coronary syndrome in humans among the ACS-free cohort (p-for-interaction=.09).
“no such association was observed among the ACS-free cohort (p-for-interaction=.09; Table).”
Humansamong the ACS-free cohort
Association of Multiple Environmental Exposures and Acute Coronary Syndrome Outcomes
ESC Congress 2026 abstract
Ramadan fasting
no changein humans1
1 study
Ramadan fasting
no changein humans1
Ramadan fasting was not clearly linked with acute coronary syndrome in humans (multivariate analysis, overall cohort).
“According to the results of the multivariate analysis, the period of Ramadan is not associated with increase of risk of SCA”
Humansmultivariate analysis, overall cohort
The risk of acute coronary syndrome in Ramadan
La Tunisie medicale
Effects
3Mortality
upin humans1
1 study
Mortality
upin humans1
Acute coronary syndrome increases mortality in humans (compared with men).
“Women with ACS also have longer treatment delays, receive fewer invasive interventions, and have higher mortality rates.”
Reviewcompared with menfemales
Cardiology clinics
Physical function
downin humans1
1 study
Physical function
downin humans1
Acute coronary syndrome is linked with worse physical function in humans (hospitalized for ACS) (Barthel: 71.2±11.3, p<0.001; Lawton: 4.8±2.5, p=0.02).
“At 30 days, a significant functional decline was observed (Barthel: 71.2±11.3, p<0.001; Lawton: 4.8±2.5, p=0.02), which persisted at one year.”
Humanshospitalized for ACS30 daysn = 110
Detrimental impact of acute coronary syndrome on the independence of the elderly
Archivos peruanos de cardiologia y cirugia cardiovascular
Telomerase activity
downin humans1
1 study
Telomerase activity
downin humans1
Acute coronary syndrome is linked with lower telomerase activity in humans (compared with healthy donors).
“Compared to healthy donors, ACS patients demonstrated the lowest telomerase activity in both CD4+CD28+and CD4+CD28null T cells.”
Humanscompared with healthy donorsCD4+CD28+ and CD4+CD28null T cells
Aging and disease
Upstream
2Prediabetes
no changein humans1
1 study
Prediabetes
no changein humans1
Prediabetes were not clearly linked with acute coronary syndrome in humans after 1:1 propensity score matching.
“The general association between prediabetes and ACS is similar to that in individuals with normal glycemic status.”
Humansafter 1:1 propensity score matching
British journal of hospital medicine (London, England : 2005)
Irisin
no changein humans1OR 1
1 study
Irisin
no changein humans1OR 1
Irisin was not clearly linked with acute coronary syndrome in otherwise healthy individuals (OR 1.00, 95% CI 0.99-1.00).
“there was no association between irisin levels and ACS in otherwise healthy individuals (odds ratio: 1.00 95% confidence interval: (0.99-1.00)).”
Humansin otherwise healthy individuals
International journal of obesity (2005)
Associations
74Air pollution
upin humans3
3 studies
Air pollution
upin humans3
Air pollution is linked with a higher risk of acute coronary syndrome in humans.
“All air pollutants analyzed increase the number of ACS hospital admission in the five locations evaluated.”
Humans
Medicina clinica
Air pollution is linked with a higher risk of acute coronary syndrome in humans (non-continuously vaccinated elderly population).
“Increases in air pollution concentrations of CO, NO2, PM10 or PM2.5 and decreases in temperature significantly influenced the risk of ACS for the non-continuously vaccinated elderly population”
Humansnon-continuously vaccinated elderly population3days prior to the ACS diagnosis daten = 1,128
Vaccine
Air pollution raises the risk of acute coronary syndrome in humans.
“Air pollution also significantly affects the incidence of acute coronary syndromes through both short- and long-term exposure.”
Review
Kardiologia polska
Major adverse cardiovascular events
upin humans2+42%
2 studies
Major adverse cardiovascular events
upin humans2+42%
Acute coronary syndrome is associated with major adverse cardiovascular events in humans (ACS patients undergoing coronary angiography) (42%).
“In all, 42% of the patients had MACEs and 25% had post-ACS heart failure.”
HumansACS patients undergoing coronary angiography
International journal of cardiology
Acute coronary syndrome is associated with major adverse cardiovascular events in humans after acute coronary syndrome (Overall 90-day MACE rate of 4.1%; nearly half of first-year adverse events occur within 90 days).
“Post-ACS MACE clusters within 90 days after discharge.”
Reviewafter acute coronary syndrome90 days after discharge
Georgian medical news
Lipoprotein
mixedin humans1upin humans1HR 2.04
2 studies
Lipoprotein
mixedin humans1upin humans1HR 2.04
Acute coronary syndrome is associated with lipoprotein in humans following acute coronary syndrome (+30.0% at Days 4–7; +15.0% at Day 30; return to baseline at follow-up).
“Lp(a) increased following ACS (p < 0.001), peaking at Days 4-7 (+30.0 %, p = 0.0001)”
Humansfollowing acute coronary syndrome≥6 monthsn = 225
Temporal changes in lipoprotein(a) after acute coronary syndrome
American journal of preventive cardiology
Lipoprotein is linked with a higher risk of acute coronary syndrome in humans (high versus low Lp(a) groups (>50 mg/dl vs <30 mg/dl) adjusted for age and BMI) (HR 2.04 (95% CI, 1.0-4.2; P = 0.05)).
“the hazard ratio was 2.04 (95% CI, 1.0-4.2; P = 0.05) in the high versus low Lp(a) groups”
Humanshigh versus low Lp(a) groups (>50 mg/dl vs <30 mg/dl) adjusted for age and BMIup to 8 yearsmalesn = 755
Elevated lipoprotein(a) as a predictor for coronary events in older men
Journal of lipid research
Telomere length
upin humans1downin humans1OR 1.87
2 studies
Telomere length
upin humans1downin humans1OR 1.87
Telomere length is linked with a higher risk of acute coronary syndrome in humans (carriers of shorter telomeres, per 1 LTL decile) (adjusted OR=1.87 (95% CI 1.70-2.06)).
“The carriers of shorter telomeres had increased 15-year risk of MI/ACS with adjusted OR=1,87 (95% CI 1,70-2,06) per 1 LTL decile independent of other factors.”
Humanscarriers of shorter telomeres, per 1 LTL decileleukocytes15 years
Advances in gerontology = Uspekhi gerontologii
Acute coronary syndrome is associated with telomere length in humans (before multiple adjustments) (P<0.001).
“We detected significantly shorter LTL in women with ACS (P<0.001), but the difference disappeared after multiple adjustments.”
Humansbefore multiple adjustmentsfemales
Clinica chimica acta; international journal of clinical chemistry
Noncalcified plaque volume
upin humans1HR 5.11
1 study
Noncalcified plaque volume
upin humans1HR 5.11
Noncalcified plaque volume predicts acute coronary syndrome in humans (noncalcified plaque volume ≥32 mm3) (Patient-level adjusted HR 5.11, 95% CI 2.49–10.46).
“NCPV ≥32 mm3: adjusted HR: 5.11; 95% CI: 2.49-10.46; P < 0.001) with consistent results in the validation cohort.”
Humansnoncalcified plaque volume ≥32 mm3coronary artery
JACC. Cardiovascular imaging
Total plaque volume
upin humans1HR 2.92
1 study
Total plaque volume
upin humans1HR 2.92
Total plaque volume predicts acute coronary syndrome in humans (total plaque volume ≥55 mm3) (Patient-level adjusted HR 2.92, 95% CI 1.65–5.16).
“patient-level ACS (TPV ≥55 mm3: adjusted HR: 2.92; 95% CI: 1.65-5.16; P < 0.001;”
Humanstotal plaque volume ≥55 mm3coronary artery
JACC. Cardiovascular imaging
Age
upin humans1OR 1.02
1 study
Age
upin humans1OR 1.02
Age predicts acute coronary syndrome in humans (OR 1.02; 95% CI 1.02-1.03).
“age (OR 1.02; 95% CI 1.02-1.03; p<0.001)”
Humans26.8±14.5 monthsn = 60,000
AHA Scientific Sessions 2026 abstract
C-reactive protein
upin humans1OR 1.06
1 study
C-reactive protein
upin humans1OR 1.06
C-reactive protein predicts acute coronary syndrome in humans (OR 1.06; 95% CI 1.03-1.09).
“hs-CRP (OR 1.06; 95% CI 1.03-1.09; p<0.001)”
Humans26.8±14.5 monthsn = 60,000
AHA Scientific Sessions 2026 abstract
Napkin-ring sign
upin humans1OR 3.35
1 study
Napkin-ring sign
upin humans1OR 3.35
Napkin-ring sign predicts acute coronary syndrome in humans (OR 3.35; 95% CI 3.05-3.67).
“napkin ring sign (OR 3.35; 95% CI 3.05-3.67; p<0.001)”
Humans26.8±14.5 monthsn = 60,000
AHA Scientific Sessions 2026 abstract
Positive remodeling
upin humans1OR 9.29
1 study
Positive remodeling
upin humans1OR 9.29
Positive remodeling predicts acute coronary syndrome in humans (OR 9.29; 95% CI 6.38-13.53).
“as did positive remodeling (OR 9.29; 95% CI 6.38-13.53; p<0.001)”
Humans26.8±14.5 monthsn = 60,000
AHA Scientific Sessions 2026 abstract
Twice-weekly portable electrocardiogram screening
downin humans1
1 study
Twice-weekly portable electrocardiogram screening
downin humans1
Twice-weekly portable electrocardiogram screening lowers the risk of acute coronary syndrome in humans (10 vs. 21).
“Participants in the iECG care group were less likely to have an acute coronary syndrome event during the follow-up period than in the RC group (10 vs. 21, P = 0.044; ).”
Human trial4.2 yearsn = 997
European heart journal open
All 74Fewer
Trial sponsors
Company6 trialsPhase 423,757 people
Company4 trialsPhase 413,865 people
Company4 trialsPhase 49,765 people
Novartis Pharmaceuticals Corporation
Company3 trialsPhase 41,005 people
Company3 trialsPhase 4154 people
Company3 trialsPhase 4154 people
Company1 trialPhase 4499 people
Company1 trialPhase 4204 people
Funding
5 grants since 2018National Heart, Lung, and Blood Institute$4.4MJapan Society for the Promotion of Science¥4.3MSwiss National Science Foundation
National Heart, Lung, and Blood InstituteMassachusetts General Hospital$835K2022–2027
National Heart, Lung, and Blood InstituteUT Southwestern Medical Center$669K2025–2030
Swiss National Science Foundation2020–2025
National Heart, Lung, and Blood InstituteColumbia University Health Sciences$513K2017–2022
Japan Society for the Promotion of ScienceKyoto University¥4.3M2019–2025